How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

DT

NASDAQ:DTIL
Get a brief AI stock analysisSaves ~ 15 minutes of your time

DT

Precision BioSciences IncNASDAQ DTIL Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is DTIL undervalued compared to its fair value?

The fair value of DTIL stock is hidden USD. Relative to the market price of 9.95 USD Precision BioSciences Inc is hidden.

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The company is headquartered in Durham, North Carolina and currently employs 198 full-time employee...[More about valuation]

Precision BioSciences Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.069 $B

Price:

9.95 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

1.696

FINANCIALS

Precision BioSciences financial for reporting period

Income Statement

0.018 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0042 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0086 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.018 B 100%
-0.0042 B -24%
0.0086 B 49%

Balance Sheet

0.18 B
0.037 B


Financial Position Analysis

Assets

0.18 B
Current Assets
0.16 B
Total non-current assets
0.024 B

Total current liabilities
0.033 B
Total non-current liabilities
0.11 B

Cash Flow Statement

-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Precision BioSciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-93 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-208 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-16 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Precision Rating

Is DTIL attractive for investment based on fundamental analysis?

DTIL stock rating is hidden. Precision BioSciences is a hidden by Eyestock methodology.

Get DTIL Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-48

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

3.105

Debt / Equity ratio:

0.752

ROE:

-93

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

DTIL analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for DTIL to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Precision BioSciences Inc dividends

DTIL dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About DTIL stock

About the company Precision BioSciences Inc

Market cap $B

0.069

Dividend yield

Shares outstanding

111.296 B

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The company is headquartered in Durham, North Carolina and currently employs 198 full-time employees. The company went IPO on 2019-03-28. The company is developing ex vivo allogeneic CAR T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its owned ARCUS genome editing platform. The firm's ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. Its subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.

DTIL profile

  • Ticker

    DTIL

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    28 March 2019

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    198

  • City

    Durham

  • Address

    302 E Pettigrew St Ste A100

  • Cusip

    74019P108

Frequently Asked Questions

What sector does Precision operate in?

Precision operates in Healthсare sector

What is market cap of Precision?

Market cap of Precision is 0.069 USD as of 24 Jul 2024

What is market price of one DTIL stock?

Market price of one DTIL stock is 9.95 USD as of 24 Jul 2024

What is Precision revenue?

According to the recent report Precision revenue is 17.584

What is Precision net income?

According to the recent report Precision net icnome is 8.588

What is Precision net income growh rate?

Net income growth rate of Precision is 853